Skip to content
  • Sunday, 26 July 2026
  • 3:05 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Glioblastoma Research Reveals Skull Erosion and Immune System Reprogramming Reshaping Treatment Strategies
Stem Cell & Regenerative Medicine

Glioblastoma Research Reveals Skull Erosion and Immune System Reprogramming Reshaping Treatment Strategies

Dwi Wanna Jun 30, 2026 0

The medical community has long viewed glioblastoma multiforme (GBM) as a localized, albeit highly aggressive, malignancy confined within the blood-brain…

Read More
Pharmaceutical R&D

The Eliquis Patent Cliff: A $14.2 Billion Revenue Erosion Set to Reshape Pharmaceutical Giants

Teuku Ryan May 27, 2026 0

The impending loss of exclusivity for Eliquis (apixaban) is poised to become one of the most significant revenue-generating events in…

Read More
Stem Cell & Regenerative Medicine

Glioblastoma Research Reveals Skull Bone Erosion and Immune System Manipulation by Aggressive Brain Tumors

Dwi Wanna Apr 10, 2026 0

In a landmark study published on October 3 in the journal Nature Neuroscience, researchers from the Montefiore Einstein Comprehensive Cancer…

Read More
Coordinated molecular and physiological adaptations enable activity at subfreezing temperature in the snow fly Chionea alexandrianaScience News: A Century of Empowering Public Understanding of Science, Medicine, and TechnologyTop pharma companies set sustainability goals, but emissions are still increasingRising Therapy-Related Leukemia Rates Signal New Testing Demands for Clinical Labs
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ